Verapamil Ameliorates Hepatic Metaflammation by Inhibiting Thioredoxin-Interacting Protein/NLRP3 Pathways
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Verapamil Ameliorates Hepatic Metaflammation by Inhibiting Thioredoxin-Interacting Protein/NLRP3 Pathways
Authors
Keywords
-
Journal
Frontiers in Endocrinology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-10-31
DOI
10.3389/fendo.2018.00640
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Liraglutide attenuates lipopolysaccharide-induced acute lung injury in mice
- (2016) Feng Zhou et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Inflammasomes in non-alcoholic fatty liver disease
- (2016) George L Tipoe Frontiers in Bioscience-Landmark
- Interleukin-1 and inflammasomes in alcoholic liver disease/acute alcoholic hepatitis and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
- (2016) Herbert Tilg et al. HEPATOLOGY
- The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
- (2016) Elena Buzzetti et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- New insights into salvianolic acid A action: Regulation of the TXNIP/NLRP3 and TXNIP/ChREBP pathways ameliorates HFD-induced NAFLD in rats
- (2016) Chunchun Ding et al. Scientific Reports
- Reactive Oxygen Species-Induced TXNIP Drives Fructose-Mediated Hepatic Inflammation and Lipid Accumulation Through NLRP3 Inflammasome Activation
- (2015) Xian Zhang et al. ANTIOXIDANTS & REDOX SIGNALING
- Bee’s honey attenuates non-alcoholic steatohepatitis-induced hepatic injury through the regulation of thioredoxin-interacting protein–NLRP3 inflammasome pathway
- (2015) Jia Xiao et al. EUROPEAN JOURNAL OF NUTRITION
- NAFLD: A multisystem disease
- (2015) Christopher D. Byrne et al. JOURNAL OF HEPATOLOGY
- Evolving Concepts in the Pathogenesis of NASH: Beyond Steatosis and Inflammation
- (2014) William Peverill et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Thioredoxin-interacting protein mediates hepatic lipogenesis and inflammation via PRMT1 and PGC-1α regulation in vitro and in vivo
- (2014) Min-Jung Park et al. JOURNAL OF HEPATOLOGY
- Resveratrol ameliorates hepatic metaflammation and inhibits NLRP3 inflammasome activation
- (2014) Soo Jin Yang et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Pharmacological correction of obesity-induced autophagy arrest using calcium channel blockers
- (2014) Hwan-Woo Park et al. Nature Communications
- Quercetin and allopurinol reduce liver thioredoxin-interacting protein to alleviate inflammation and lipid accumulation in diabetic rats
- (2013) Wei Wang et al. BRITISH JOURNAL OF PHARMACOLOGY
- Epigallocatechin gallate attenuates fibrosis, oxidative stress, and inflammation in non-alcoholic fatty liver disease rat model through TGF/SMAD, PI3 K/Akt/FoxO1, and NF-kappa B pathways
- (2013) Jia Xiao et al. EUROPEAN JOURNAL OF NUTRITION
- Inflammation as a potential link between nonalcoholic fatty liver disease and insulin resistance
- (2013) Mohamed Asrih et al. JOURNAL OF ENDOCRINOLOGY
- Caspase-1 as a Central Regulator of High Fat Diet-Induced Non-Alcoholic Steatohepatitis
- (2013) Laura J. Dixon et al. PLoS One
- Carbachol ameliorates lipopolysaccharide-induced intestinal epithelial tight junction damage by down-regulating NF-κβ and myosin light-chain kinase pathways
- (2012) Ying Zhang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Thioredoxin-Interacting Protein Mediates ER Stress-Induced β Cell Death through Initiation of the Inflammasome
- (2012) Christine M. Oslowski et al. Cell Metabolism
- Preventing -Cell Loss and Diabetes With Calcium Channel Blockers
- (2012) G. Xu et al. DIABETES
- The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
- (2012) Naga Chalasani et al. HEPATOLOGY
- Inflammasomes in liver diseases
- (2012) Gyongyi Szabo et al. JOURNAL OF HEPATOLOGY
- Effects of calcium channel blockers on glucose tolerance, inflammatory state, and circulating progenitor cells in non-diabetic patients with essential hypertension: a comparative study between Azelnidipine and amlodipine on glucose tolerance and endothelial function - a crossover trial (AGENT)
- (2011) Kosuke Fukao et al. Cardiovascular Diabetology
- Current therapeutic strategies in non-alcoholic fatty liver disease
- (2011) J. K. Dowman et al. DIABETES OBESITY & METABOLISM
- NALP-3 inflammasome silencing attenuates ceramide-induced transepithelial permeability
- (2011) Narasaiah Kolliputi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Lack of interleukin-1α or interleukin-1β inhibits transformation of steatosis to steatohepatitis and liver fibrosis in hypercholesterolemic mice
- (2011) Yehuda Kamari et al. JOURNAL OF HEPATOLOGY
- Inflammasome is a central player in the induction of obesity and insulin resistance
- (2011) R. Stienstra et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Inflammasomes
- (2010) Kate Schroder et al. CELL
- The NLRP3 Inflammasome: A Sensor for Metabolic Danger?
- (2010) K. Schroder et al. SCIENCE
- Kupffer cells promote hepatic steatosis via interleukin-1β-dependent suppression of peroxisome proliferator-activated receptor α activity
- (2009) Rinke Stienstra et al. HEPATOLOGY
- Thioredoxin-interacting protein links oxidative stress to inflammasome activation
- (2009) Rongbin Zhou et al. NATURE IMMUNOLOGY
- The role of interleukins in insulin resistance and type 2 diabetes mellitus
- (2009) Bruno Fève et al. Nature Reviews Endocrinology
- Treatment with an Interleukin 1 beta antibody improves glycemic control in diet-induced obesity
- (2008) O. Osborn et al. CYTOKINE
- Inhibition of hepatic interleukin-18 production by rosiglitazone in a rat model of nonalcoholic fatty liver disease
- (2008) Hai-Ning Wang et al. WORLD JOURNAL OF GASTROENTEROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started